Načítá se...
Bevacizumab Monotherapy as Salvage Therapy for Advanced clear cell Renal Cell Carcinoma (ccRCC) Pretreated with Targeted Drugs
Bevacizumab has shown benefit in the first line setting in combination with interferon; however, data on use as monotherapy are limited. This retrospective analysis of 71 patients assesses the efficacy of bevacizumab monotherapy in patients who progressed on other targeted drugs. Bevacizumab monothe...
Uloženo v:
| Vydáno v: | Clin Genitourin Cancer |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4965701/ https://ncbi.nlm.nih.gov/pubmed/26404107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2015.07.010 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|